Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-03-02

Clinical Trial Update: Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes [Phase 4]

View source ↗

Summary

The Phase 4 trial comparing Dextenza to prednisolone acetate after cataract surgery in diabetic patients has been withdrawn. No further results are available in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dextenza (Dexamethasone)
  • Prednisolone Acetate ophthalmic suspension (Pred Forte) (prednisolone acetate)

Snippet

Sponsor: Baylor Research Institute | Conditions: Cataract Diabetic, Macula Edema | Phase 4 | Status: WITHDRAWN